Annual Drug Patent Expirations for IONSYS Ionsys is a drug marketed by The Medicines Co and is included in one NDA. There are eight patents protecting this drug. This drug…
Source
New patent expiration for The Medicines drug IONSYS Read Post »
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPatentWatch.com
Source
New tentative approval for MYLAN drug efavirenz, emtricitabine and tenofovir alafenamide Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Ireland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
Source
Which pharmaceutical companies have the most SPCs in Ireland? Read Post »
A recent study published in JAMA Health Forum sheds light on the impact of biosimilar competition on patient out-of-pocket (OOP) costs for biologic drugs in the United States. The research,…
Source
Biosimilar Competition Does Not Reduce Patient Out-of-Pocket Costs for Biologic Drugs Read Post »
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPatentWatch.com
Source
New tentative approval for MYLAN drug efavirenz, emtricitabine and tenofovir alafenamide Read Post »
This chart shows the pharmaceutical companies with the most capsule dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most capsule dosed drugs…
Source
Which pharmaceutical companies have the most capsule dosed drugs? Read Post »
Annual Drug Patent Expirations for ZEPBOUND Zepbound is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…
Source
Annual Drug Patent Expirations for PREVDUO Prevduo is a drug marketed by Slayback Pharma Llc and is included in one NDA. It is available from one supplier. There are two…
Source
Annual Drug Patent Expirations for XOFLUZA Xofluza is a drug marketed by Genentech Inc and is included in two NDAs. It is available from one supplier. There are eight patents…
Source
Annual Drug Patent Expirations for SPINRAZA Spinraza is a drug marketed by Biogen Idec and is included in one NDA. It is available from one supplier. There are eight patents…
Source
Get new actionable insights and updates from BiotechBlog
